Antibiotic Treatment for Mediastinitis
For mediastinitis treatment, broad-spectrum antibiotics targeting both gram-positive and gram-negative bacteria, including anaerobes, are recommended as initial therapy, with specific regimens determined by the suspected etiology and local resistance patterns. 1
Treatment Based on Etiology
Granulomatous Mediastinitis (Active Inflammatory Process)
- Amphotericin B (0.7-1.0 mg/kg/day) is recommended as initial therapy for severe obstructive complications of mediastinal histoplasmosis 2
- After clinical improvement, transition to itraconazole 200 mg once or twice daily to complete treatment 2
- For less severe cases, itraconazole 200 mg once or twice daily for 6-12 months may be used 2
- Prednisone 40-80 mg daily for 2 weeks should be considered in cases with major airway obstruction 2
Fibrosing Mediastinitis (Chronic Fibrotic Process)
- Antifungal treatment is generally not recommended as most authorities believe it does not improve outcomes 2
- A 12-week trial of itraconazole 200 mg once or twice daily may be considered if clinical findings cannot differentiate fibrosing mediastinitis from granulomatous mediastinitis 2
- Intravascular stents are recommended for selected patients with pulmonary vessel obstruction 2
Post-Surgical/Post-Traumatic Mediastinitis
For MRSA-associated mediastinitis:
For polymicrobial infections (common after esophageal perforation):
- Broad-spectrum beta-lactams alone or combined with metronidazole to cover both gram-positive, gram-negative, and anaerobic bacteria 1
Duration of Therapy
- For post-surgical mediastinitis: 4-6 weeks of appropriate antibiotic therapy 2
- For granulomatous mediastinitis: 6-12 weeks of antifungal therapy 2
- Longer courses may be necessary based on clinical response and imaging findings 2
Adjunctive Therapies
- Surgical drainage is essential in most cases of acute mediastinitis 4
- Hyperbaric oxygen therapy may provide additional benefit when combined with appropriate antibiotics 5
- For fungal mediastinitis, corticosteroids might be beneficial in cases with significant inflammation and obstruction 2
Special Considerations
- In patients with renal dysfunction, therapeutic drug monitoring should be considered when using agents like linezolid 6
- For multidrug-resistant organisms, newer agents such as polymyxins, glycylglycines, or new beta-lactam/beta-lactamase inhibitor combinations may be necessary 1
- Early and aggressive treatment is crucial due to the high mortality rate associated with mediastinitis 4
Common Pitfalls to Avoid
- Failing to distinguish between granulomatous (potentially responsive to antifungals) and fibrosing mediastinitis (generally not responsive) 2
- Delaying surgical drainage when indicated, which can lead to increased mortality 4
- Inadequate spectrum of antimicrobial coverage, particularly in polymicrobial infections 1
- Not considering local resistance patterns when selecting empiric therapy 1
Remember that mediastinitis remains a severe infectious disease with high mortality, requiring prompt diagnosis and aggressive treatment with appropriate antibiotics and, in many cases, surgical intervention 1, 4.